AGT and graft versus host disease: Blocking Ang II signaling protects against neurodegenerative processes and promotes longevity in an animal model, suggesting targeting Ang II signaling as a therapeutic strategy in inflammatory diseases, including GVHD-related dry eye disease and aging-related changes [121].